Previous
Previous

GEn1E Lifesciences Announces Partnership with BARDA to Advance its AI-powered Endotyping Program for ARDS Patients to Further Accelerate its Novel, Lead Compound GEn-1124

Next
Next

Verdigris Secures $10 Million from DCVC and Solea Energy